These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7930339)

  • 1. Pharmacokinetics of methylprednisolone in elderly and young healthy males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Am Geriatr Soc; 1994 Oct; 42(10):1118-22. PubMed ID: 7930339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure.
    Tornatore KM; Venuto RC; Logue G; Davis PJ
    J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol pharmacodynamic response to long-term methylprednisolone in renal transplant recipients.
    Tornatore KM; Reed K; Walshe JJ; Venuto RC
    Pharmacotherapy; 1994; 14(1):111-8. PubMed ID: 8159595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated assessment of methylprednisolone pharmacokinetics during chronic immunosuppression in renal transplant recipients.
    Tornatore KM; Reed KA; Venuto RC
    Ann Pharmacother; 1995 Feb; 29(2):120-4. PubMed ID: 7756707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients.
    Tornatore KM; Biocevich DM; Reed K; Tousley K; Singh JP; Venuto RC
    Transplantation; 1995 Mar; 59(5):729-36. PubMed ID: 7886801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative methylprednisolone pharmacokinetics in renal transplant patients receiving double- or triple-drug immunosuppression.
    Tornatore KM; Walshe JJ; Reed KA; Holdsworth MT; Venuto RC
    Ann Pharmacother; 1993 May; 27(5):545-9. PubMed ID: 8347899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamic response of methylprednisolone in premenopausal renal transplant recipients.
    Tornatore KM; Gilliland-Johnson KK; Farooqui M; Reed KA; Venuto RC
    J Clin Pharmacol; 2004 Sep; 44(9):1003-11. PubMed ID: 15317828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration.
    Rohatagi S; Barth J; Möllmann H; Hochhaus G; Soldner A; Möllmann C; Derendorf H
    J Clin Pharmacol; 1997 Oct; 37(10):916-25. PubMed ID: 9505983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P
    Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methylprednisolone during acute renal allograft rejection.
    Tornatore KM; Walshe JJ; Reed K; Venuto RC
    Clin Transplant; 1995 Apr; 9(2):74-8. PubMed ID: 7599405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone and cortisol metabolism during the early post-renal transplant period.
    Tornatore KM; Reed KA; Venuto RC
    Clin Transplant; 1995 Dec; 9(6):427-32. PubMed ID: 8645883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the pharmacokinetics of methylprednisolone in black and white renal transplant recipients.
    Tornatore KM; Reed KA; Venuto RC
    Pharmacotherapy; 1993; 13(5):481-6. PubMed ID: 8247916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of high-dose methylprednisolone in children.
    Ito S; Kusunoki Y; Oka T; Ito Y; Okuno A; Yoshioka H
    Dev Pharmacol Ther; 1992; 19(2-3):99-105. PubMed ID: 1340442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.